Anxiety-like responses to stress are accompanied by elevation of brain cytokine-mRNAs. Because cytokines microinjected into central-amygdala (CeA) substitute for stress in a behavioral paradigm, the possibility was raised that cytokines increased by stress influence behavior by affecting CeA-neural activity. Previously, cytokines increased firing-rate of CeA-neurons comparable to that induced by corticotropinreleasing factor (CRF). In this investigation, tumor-necrosis-factor-a (TNFa) increased amplitude, but not frequency of mEPSCs from CeA-neurons. Additionally, TNFa decreased the threshold for triggering action potentials from CeA-neurons without altering membrane-properties during current-clamp recording. Glutamate-receptor-antagonist blockade of mEPSCs and the TNFa-induced reduction in firing threshold implicated glutamate in these changes. A phosphatidyl-inositol-3-kinase-antagonist prevented the TNFainduced increased in amplitude of mEPSCs, documenting a TNFa intracellular influence. Additionally, TNFa increased frequency, but not amplitude of mIPSCs. CRF-receptor-antagonists were found to prevent the TNFa-induced increase in mIPSC-frequency, without altering the TNFa-induced amplitude increase in mEPSCs or the reduced threshold for action-potentials by TNFa. To clarify how TNFa was increasing CRFrelease in the presence of tetrodotoxin, the possibility tested was whether preventing glial-activation would prevent this elevated mIPSC-frequency blocked by CRF-receptor antagonists. Minocycline, which blocks glial activation, prevented the TNFa-induced increase in mIPSC-frequency -a finding consistent with glia contributing to the CRF-involvement in this TNFa action. To fully understand the means by which a CRF1-receptor-antagonist and minocycline prevent TNFa from increasing mIPSC-frequency will require further clarification. Nonetheless, these data provide convincing evidence that release of TNFa by stress could alter neural activity of CeA-neurons by influencing GABA-and glutamate function.
Introduction
Cytokines are elevated in brain following restraint stress (Porterfield et al., 2011) , social defeat stress (Wholeb et al., 2011) , withdrawal from chronic alcohol exposure (Whitman et al., 2013a) and following systemic lipopolysaccharide (LPS) administration (Qin et al., 2007; Whitman et al., 2013a) . Stress and withdrawal from chronic alcohol are known to be accompanied by anxiety-and depressive-like behaviors (Dunn et al., 1999; Breese et al., 2004 Breese et al., , 2005a Breese et al., ,b, 2011 Hammen, 2005; Lindqvist et al., 2009 ). In addition to the role of cytokines in immune function, there is a contention that cytokines may produce functional changes by being neural mediators in the CNS (Adler et al., 2006; Rostène et al., 2007; Vitkovic et al., 2000) . Evidence supporting cytokines having neural action came in part from finding the presence of cytokine receptors on neurons (Boka et al., 1994; Hermann et al., 2004; Holmes et al., 2004) . Furthermore, various studies in brain have demonstrated that cytokines can influence neural function (Belkouch et al., 2011; Churchill et al., 2008; Callewaere et al., 2006; Emch et al., 2000 Emch et al., , 2001 Gruol and Nelson, 2005; Kawasaki et al., 2008; Knapp et al., 2011; Lukáts et al., 2005; Oh et al., 2003; Santello and Volterra, 2012; Stellwagen et al., 2005; Stellwagen and Malenka, 2006; Tabarean et al., 2006; Wilkinson et al., 1993) .
To explore if brain cytokines released by stress could be linked to function, intracerebroventrical (ICV) administration of cytokines was established to substitute for the initial two withdrawals of a
